Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 3;16(4):e57565.
doi: 10.7759/cureus.57565. eCollection 2024 Apr.

Standardized Informed Consent Form for Clinicians Administering Platelet-Rich Plasma

Satvik N Pai  1   2 , Naveen Jeyaraman  3 , Ravichandran Venkatasalam  4 , Ravi Vr  5 , Swaminathan Ramasubramanian  6 , Sangeetha Balaji  6 , Arulkumar Nallakumarasamy  7 , Shilpa Sharma  8 , Bishnu P Patro  9 , Madhan Jeyaraman  10   3
Affiliations

Standardized Informed Consent Form for Clinicians Administering Platelet-Rich Plasma

Satvik N Pai et al. Cureus. .

Abstract

Introduction When it comes to medico-legal malpractice suits, lawyers and insurers tend to focus on informed consent documentation. Unfortunately, there is no standard protocol for obtaining informed consent for the use of platelet-rich plasma (PRP) injections, which might cause problems. This study aimed to mitigate this concern through the development of a standardized informed consent document for PRP injections, grounded in evidence-based practices. Materials and methods An examination of databases was conducted to explore the medico-legal ramifications associated with PRP injections, as well as the broader topic of informed consent, with a particular focus on the context of PRP injections. Moreover, interviews were carried out with healthcare providers and individuals who had received PRP injections within the preceding year, utilizing a semi-structured methodology. Results We developed an evidence-based informed consent document tailored for PRP injections. To guarantee its legal validity, the document underwent review by a legal specialist. Subsequently, our institutions implemented the finalized form for PRP injection procedures over one year. Conclusion A legally valid and evidence-based informed consent form for PRP injections would ensure patient's rights, and encourage open communication and transparency between them and the doctor. Moreover, if a lawsuit were to arise, it would serve as a critical document in the doctor's defense and withstand scrutiny from lawyers and the judiciary.

Keywords: consent; informed consent; medico-legal; platelet-rich plasma; prp.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flowchart illustrating the process entailed in the development of the informed consent document
PRP: platelet-rich plasma
Figure 2
Figure 2. A standardized informed consent form for clinicians administering platelet-rich plasma injections, Page 1
Figure 3
Figure 3. A standardized informed consent form for clinicians administering platelet-rich plasma injections, Page 2
Figure 4
Figure 4. Preparation of Platelet Rich Plasma (PRP)
RPM - Rotations per minute
See this image and copyright information in PMC

References

    1. Platelet-rich plasma and mesenchymal stem cells: exciting, but … are we there yet? Andia I, Martin JI, Maffulli N. Sports Med Arthrosc Rev. 2018;26:59–63. - PubMed
    1. Platelet-rich plasma: a comprehensive review of emerging applications in medical and Aesthetic Dermatology. White C, Brahs A, Dorton D, Witfill K. https://jcadonline.com/platelet-rich-plasma-emerging-applications-review/ J Clin Aesthet Dermatol. 2021;14:44–57. - PMC - PubMed
    1. Platelet-rich plasma (PRP): current applications in dermatology. Emer J. https://www.skintherapyletter.com/dermatology/platelet-rich-plasma-prp/ Skin Therapy Lett. 2019;24:1–6. - PubMed
    1. Autologous platelet-rich plasma in the delayed union of long bone fractures - a quasi experimental study. Ranjan R, Kumar R, Jeyaraman M, Arora A, Kumar S, Nallakumarasamy A. J Orthop. 2023;36:76–81. - PMC - PubMed
    1. Leukocyte-rich vs. leukocyte-poor platelet-rich plasma for the treatment of knee osteoarthritis. Gupta A, Jeyaraman M, Potty AG. Biomedicines. 2023;11 - PMC - PubMed

LinkOut - more resources